2017 Fiscal Year Final Research Report
Anticancer agent-resistant mechanism elucidation and new cure development through cytokine in oral cancer.
| Project/Area Number |
16K20593
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Surgical dentistry
|
|---|
| Research Institution | Kumamoto University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
Nakayama Hideki 熊本大学, 医学部附属病院, 教授 (70381001)
|
|---|
| Project Period (FY) |
2016-04-01 – 2018-03-31
|
| Keywords | SAS / 抗癌剤耐性 / fibronectin |
|---|
| Outline of Final Research Achievements |
I studied anticancer agent-resistant mechanism にの elucidation in fibronectin, but cell proliferation was not able to weigh it by the restraint experiment strong expression of fibronectin because a difference had appeared. I performed expression of integrin receptor restraint, strong expression, but was not able to weigh it because a difference had gone to a cell shape, the adhesion. I was not able to elucidate it about anticancer agent-related mechanism in the direct participation of fibronectin than the above.
|
| Free Research Field |
歯科口腔外科
|
